Ziren Kong, attending physician from Department of Head and Neck Surgery, Cancer Hospital, Chinese Academy of Medical Sciences. I focused on the development and translation of radiopharmaceuticals to advance precision management of head and neck cancer. I have 26 published SCI-indexed papers as first or corresponding author (including equally contributions), and representative articles was published in Nature (2024), Cancer Discovery (2025) and Clinical Cancer Research (2026).